Skip Navigation


Cardiovascular Research Advance Access originally published online on December 10, 2008
Cardiovascular Research 2009 81(4):686-694; doi:10.1093/cvr/cvn339
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
81/4/686    most recent
cvn339v2
cvn339v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Calloe, K.
Right arrow Articles by Antzelevitch, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Calloe, K.
Right arrow Articles by Antzelevitch, C.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

A transient outward potassium current activator recapitulates the electrocardiographic manifestations of Brugada syndrome

Kirstine Calloe1,*,{dagger}, Jonathan M. Cordeiro2,{dagger}, José M. Di Diego2, Rie S. Hansen3, Morten Grunnet1,3, Søren Peter Olesen1 and Charles Antzelevitch2

1 The Danish National Research Foundation Centre for Cardiac Arrhythmia, Department of Biomedical Sciences 12.5.10, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark
2 Masonic Medical Research Laboratory, Utica, NY, USA
3 NeuroSearch A/S, Ballerup, Denmark

* Corresponding author. Tel: +45 3532 7134; fax: +45 3532 7555. E-mail address: kirstinec{at}mfi.ku.dk

Aims: Transient outward potassium current (Ito) is thought to be central to the pathogenesis of the Brugada syndrome (BrS). However, an Ito activator has not been available with which to validate this hypothesis. Here, we provide a direct test of the hypothesis using a novel Ito activator, NS5806.

Methods and results: Isolated canine ventricular myocytes and coronary-perfused wedge preparations were used. Whole-cell patch-clamp studies showed that NS5806 (10 µM) increased peak Ito at +40 mV by 79 ± 4% (24.5 ± 2.2 to 43.6 ± 3.4 pA/pF, n = 7) and slowed the time constant of inactivation from 12.6 ± 3.2 to 20.3 ± 2.9 ms (n = 7). The total charge carried by Ito increased by 186% (from 363.9 ± 40.0 to 1042.0 ± 103.5 pA·ms/pF, n = 7). In ventricular wedge preparations, NS5806 increased phase 1 and notch amplitude of the action potential in the epicardium, but not in the endocardium, and accentuated the ECG J-wave, leading to the development of phase 2 re-entry and polymorphic ventricular tachycardia (n = 9). Although sodium and calcium channel blockers are capable of inducing BrS only in right ventricular (RV) wedge preparations, the Ito activator was able to induce the phenotype in wedges from both ventricles. NS5806 induced BrS in 4/6 right and 2/10 left ventricular wedge preparations.

Conclusion: The Ito activator NS5806 recapitulates the electrographic and arrhythmic manifestation of BrS, providing evidence in support of its pivotal role in the genesis of the disease. Our findings also suggest that a genetic defect leading to a gain of function of Ito could explain variants of BrS, in which ST-segment elevation or J-waves are evident in both right and left ECG leads.

KEYWORDS Transient outward potassium current; Ito; Brugada syndrome; Re-entry; Arrhythmia


Time for primary review: 17 days

{dagger} These authors contributed equally to this work.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Article

Arrhythmogenic Brugada syndrome substrate: a proof of principle
Joachim R. Ehrlich
Cardiovasc Res 2009 81: 635-636. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Eur Heart JHome page
G.-B. Nam, K.-H. Ko, J. Kim, K.-M. Park, K.-S. Rhee, K.-J. Choi, Y.-H. Kim, and C. Antzelevitch
Mode of onset of ventricular fibrillation in patients with early repolarization pattern vs. Brugada syndrome
Eur. Heart J., October 29, 2009; (2009) ehp423v1.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.